{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T18:29:19Z","timestamp":1781893759754,"version":"3.54.5"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.msard.2025.106323","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T22:45:02Z","timestamp":1739313902000},"page":"106323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Thyroid comorbidities do not seem to negatively impact multiple sclerosis course: A single centre cohort study"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5945-2317","authenticated-orcid":false,"given":"Saridas","family":"Furkan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saridas Mercan","family":"Filiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koc Emine","family":"Rabia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cander","family":"Soner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turan Omer","family":"Faruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.msard.2025.106323_bib0001","first-page":"10","article-title":"Pathology of the thyroid gland and multiple sclerosis: a possible influence on efficacy and tolerability of treatment","volume":"109","author":"Bagir","year":"2009","journal-title":"Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova."},{"key":"10.1016\/j.msard.2025.106323_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577468","article-title":"Thyroid hormone and thyromimetics inhibit myelin and axonal degeneration and oligodendrocyte loss in EAE","volume":"352","author":"Chaudhary","year":"2021","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.msard.2025.106323_bib0003","article-title":"Endocrine and multiple sclerosis outcomes in patients with autoimmune thyroid events in the alemtuzumab CARE-MS studies","volume":"9","author":"Dayan","year":"2023","journal-title":"Mult. Scler. J. Exp. Transl. Clin"},{"issue":"5","key":"10.1016\/j.msard.2025.106323_bib0004","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1007\/s00415-012-6790-1","article-title":"Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis","volume":"260","author":"Dobson","year":"2013","journal-title":"J. Neurol."},{"issue":"9","key":"10.1016\/j.msard.2025.106323_bib0005","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1177\/1352458514521311","article-title":"Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study","volume":"20","author":"Frisullo","year":"2014","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106323_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105103","article-title":"The association of multiple sclerosis with thyroid disease: a meta-analysis","volume":"80","author":"Gautam","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"4","key":"10.1016\/j.msard.2025.106323_bib0007","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s10072-018-3640-7","article-title":"Multiple sclerosis and oncocytic thyroid carcinoma: fortuitous or drug-related association?","volume":"40","author":"Handra-Luca","year":"2019","journal-title":"Neurol. Sci."},{"issue":"13","key":"10.1016\/j.msard.2025.106323_bib0008","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1177\/1352458513485148","article-title":"Increased thyroid autoimmunity among women with multiple sclerosis in the postpartum setting","volume":"19","author":"Jalkanen","year":"2013","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.msard.2025.106323_bib0009","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1007\/s10238-022-00981-3","article-title":"Thyroid autoimmunity following alemtuzumab treatment in multiple sclerosis patients: a prospective study","volume":"23","author":"Kazakou","year":"2023","journal-title":"Clin. Exp. Med."},{"issue":"3","key":"10.1016\/j.msard.2025.106323_bib0010","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/cmi.2010.73","article-title":"Vitamin D and autoimmune thyroid diseases","volume":"8","author":"Kivity","year":"2011","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.msard.2025.106323_bib0011","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ebiom.2017.10.016","article-title":"Overcoming monocarboxylate transporter 8 (MCT8)-deficiency to promote human oligodendrocyte differentiation and myelination","volume":"25","author":"Lee","year":"2017","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/j.msard.2025.106323_bib0012","doi-asserted-by":"crossref","first-page":"740","DOI":"10.4103\/aian.AIAN_170_21","article-title":"Coexistence of autoantibodies and other autoimmune diseases with multiple sclerosis and related disorders - experience from the mangalore demyelinating disease registry (MANDDIR)","volume":"24","author":"Malli","year":"2021","journal-title":"Ann. Indian Acad. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2025.106323_bib0013","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1177\/1352458514564490","article-title":"A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis","volume":"21","author":"Marrie","year":"2015","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.msard.2025.106323_bib0014","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3897\/folmed.62.e47794","article-title":"Vitamin D and autoimmune thyroid diseases - a review","volume":"62","author":"Miteva","year":"2020","journal-title":"Folia. Med."},{"issue":"4","key":"10.1016\/j.msard.2025.106323_bib0015","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10238-004-0026-3","article-title":"Thyroid autoimmunity and dysfunction associated with type I interferon therapy","volume":"3","author":"Monzani","year":"2004","journal-title":"Clin. Exp. Med."},{"issue":"6","key":"10.1016\/j.msard.2025.106323_bib0016","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s00415-003-1053-9","article-title":"Prevalence of autoimmune thyroiditis and non-immune thyroid disease in multiple sclerosis","volume":"250","author":"Niederwieser","year":"2003","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2025.106323_bib0017","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3389\/fimmu.2018.00311","article-title":"The footprints of poly-autoimmunity: evidence for common biological factors involved in multiple sclerosis and hashimoto's thyroiditis","volume":"9","author":"Perga","year":"2018","journal-title":"Front Immunol."},{"issue":"5","key":"10.1016\/j.msard.2025.106323_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11051015","article-title":"Thyroid disorders in patients treated with dimethyl fumarate for multiple sclerosis: a retrospective observational study","volume":"11","author":"Renaud","year":"2022","journal-title":"Antioxidants"},{"issue":"6","key":"10.1016\/j.msard.2025.106323_bib0019","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/03009742.2016.1151072","article-title":"Vitamin D and autoimmunity","volume":"45","author":"Rosen","year":"2016","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.msard.2025.106323_bib0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1740-2557-2-9","article-title":"Co-occurrence of autoimmune thyroid disease in a multiple sclerosis cohort","volume":"2","author":"Sloka","year":"2005","journal-title":"J. Autoimmune Dis."},{"issue":"3","key":"10.1016\/j.msard.2025.106323_bib0021","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s11011-022-01138-7","article-title":"Influence of hormones in multiple sclerosis: focus on the most important hormones","volume":"38","author":"Soleimani","year":"2023","journal-title":"Metab. Brain Dis."},{"issue":"10","key":"10.1016\/j.msard.2025.106323_bib0022","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1002\/eji.201242370","article-title":"The role of 1alpha,25-dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3+ and IL-10+ CD4+ T cells","volume":"42","author":"Urry","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.msard.2025.106323_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104903","article-title":"Establishment of comorbidity target pools and prediction of drugs candidate for multiple sclerosis and autoimmune thyroid diseases based on GWAS and transcriptome data","volume":"78","author":"Wang","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"4","key":"10.1016\/j.msard.2025.106323_bib0024","doi-asserted-by":"crossref","first-page":"344","DOI":"10.5603\/PJNNS.a2023.0038","article-title":"Multiple sclerosis and autoimmune diseases - a case control study","volume":"57","author":"Wawrzyniak","year":"2023","journal-title":"Neurol. Neurochir. Pol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825000665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825000665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T04:49:04Z","timestamp":1741841344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825000665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":24,"alternative-id":["S2211034825000665"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106323","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thyroid comorbidities do not seem to negatively impact multiple sclerosis course: A single centre cohort study","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106323","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106323"}}